Ruizhi Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 2
-
- Circular RNAs in diseases 3
-
- Pregnancy and preeclampsia studies 2
-
- Antifungal resistance and susceptibility 2
-
- Prenatal Screening and Diagnostics 2
-
- Sepsis Diagnosis and Treatment 2
-
- Hemodynamic Monitoring and Therapy 2
In The Last Decade
Ruizhi Wang
14 papers receiving 387 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 239
- Molecular Biology 279
- Immunology 42
- Hepatology 14
- Oncology 46
Countries citing papers authored by Ruizhi Wang
This map shows the geographic impact of Ruizhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhi Wang more than expected).
Fields of papers citing papers by Ruizhi Wang
This network shows the impact of papers produced by Ruizhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhi Wang. The network helps show where Ruizhi Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruizhi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 1 | |
| 16 | 2019 | 14 | |
| 17 | 2014 | 139 | |
| 18 | 2013 | 186 | |
| 19 | 2006 | 1 |
About Ruizhi Wang
Ruizhi Wang is a scholar working on Cancer Research, Obstetrics and Gynecology and Otorhinolaryngology, having authored 19 papers that have together received 390 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (3 papers), Pregnancy and preeclampsia studies (2 papers), Antifungal resistance and susceptibility (2 papers), Prenatal Screening and Diagnostics (2 papers), Sepsis Diagnosis and Treatment (2 papers), Cancer-related molecular mechanisms research (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). The work is most often cited by research in Cancer Research (239 citations), Molecular Biology (279 citations) and Immunology (42 citations). Ruizhi Wang has collaborated with scholars based in China, Czechia and Canada. Frequent co-authors include Na Zhao, Shi‐Mei Zhuang, Ying Zhu, Jiao Gong, Liang‐Ji Zhou, Jine Yang, Jian‐Hong Fang, Yunfei Yuan, Wei-Hua Jia and Siwen Li. Their work appears in journals such as Hepatology, Scientific Reports and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.